There are 169 resources available
Novel mutant-selective EGFR/HER2 kinase inhibitors: Insights and perspectives
Presenter: Capucine Baldini
Session: Mutant specific inhibitors
Resources:
Slides
Webcast
IVDR clinical trial impacts and potential solutions: Industry perspective
Presenter: Alison Bond
Session: The challenges and opportunities of the EU IVD Regulation
Resources:
Slides
Webcast
Targeting PI3KCA in cancer: Are we making headway with mutant specific inhibitors?
Presenter: Antoine Italiano
Session: Mutant specific inhibitors
Resources:
Slides
Webcast
Mutant-selective degradation by kinase-targeting PROTACs: current developments
Presenter: Tanya Dorff
Session: Mutant specific inhibitors
Resources:
Slides
Webcast
Panel discussion
Presenter: All Speakers
Session: The challenges and opportunities of the EU IVD Regulation
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mutant specific inhibitors
Resources:
Webcast
Innovative clinical trial design: Patient, scientific, operational and financial considerations
Presenter: Lesley Seymour
Session: Increasing efficiency in clinical trial designs
Resources:
Slides
Webcast
Statistical considerations for efficient trial designs
Presenter: Saskia Litiere
Session: Increasing efficiency in clinical trial designs
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Increasing efficiency in clinical trial designs
Resources:
Webcast
Where are we up to with precision medicine in HCC?
Presenter: Pablo Azcue Sanroman
Session: Diving into hepatobiliary malignancies
Resources:
Slides
Webcast